UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced encouraging safety data from the ...

Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed signs of anti-tumor activity, including an unconfirmed partial ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Given that only a small fraction of patients with cancer exhibits specific markers making them eligible for effective ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Outpatient administration of CAR T-cell therapies can reduce costs and improve patient satisfaction, with evolving ...

And so Swanson and a team of researchers, with funding from the National Institute of Mental Health, began a vast, multisite randomized controlled trial comparing stimulant treatment for A.D.H.D ...

A notable escalation occurred in 2025 when the U.S. deployed the advanced Naval/Marine Expeditionary Ship Interdiction System (NMESIS) and unmanned surface vessels within Philippine territory ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...